In vitro and in vivo evaluation of medicinal carbon granules and tablet on the adsorption of acetaminophen

International Journal of Pharmaceutics

Volumn 328, Issue 2, 2007, Pages 105-111

  Yamamoto, Kenta ^a   Onishi, Hiraku ^a   Ito, Akihiko ^a   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Acetaminophen; Adsorption capacity; Granules; Medicinal carbon; Plasma concentration; Tablet

Indexed keywords

ACTIVATED CARBON; MALTITOL; PARACETAMOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPRESSION; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG GRANULE; DRUG SCREENING; GASTROINTESTINAL ABSORPTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; TABLET FORMULATION;

ACETAMINOPHEN; ADSORPTION; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIDOTES; CHARCOAL; EXCIPIENTS; INTESTINAL ABSORPTION; MALE; MALTOSE; RATS; RATS, WISTAR; SUGAR ALCOHOLS; TABLETS;

EID: 33845299819     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.07.053     Document Type: Article

References (25)

1. Alegakis A.K., Tzatzarakis M.N., Tsatsakis A.M., Vlachonikolis I.G., and Liakou V. In vitro study of oxytetracycline adsorption on activated charcoal. J. Environ. Sci. Health B 35 (2000) 559-569
2. al-Shareef A.H., Buss D.C., and Routledge P.A. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. Hum. Exp. Toxicol. 9 (1990) 95-97
3. Amitai Y., and Degani Y. Treatment of phenobarbital poisoning with multiple dose activated charcoal in an infant. J. Emerg. Med. 8 (1990) 449-450
4. Arimori K., and Nakano M. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis. J. Pharmacobiodyn. 9 (1986) 437-441
5. Bainbridge C.A., Kelly E.L., and Walking W.D. In vitro adsortpion of acetaminophen onto activated charcoal. J. Pharm. Sci. 66 (1977) 480-483
6. Cooney D.O. In vitro adsorption of phenobarbital, chlorpheniramine maleate, and theophylline by four commercially available activated charcoal suspensions. J. Toxicol. Clin. Toxicol. 33 (1995) 213-217
7. Fricke R.F., and Jorge J. Assessment of efficacy of activated charcoal for treatment of acute T-2 toxin poisoning. J. Toxicol. Clin. Toxicol. 28 (1990) 421-431
8. Galinsky R.E., and Levy G. Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. J. Pharmacol. Exp. Ther. 219 (1981) 14-20
9. Granados-Soto V., Flores-Murrieta F.J., Lopez-Munoz F.J., Salazar L.A., Villarreal J.E., and Castaneda-Hernandez G. Relationship between paracetamol plasma levels and its analgesic effect in the rat. J. Pharm. Pharmacol. 44 (1992) 741-744
10. Gregus Z., Madhu C., and Klaassen C.D. Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. J. Pharmacol. Exp. Ther. 244 (1988) 91-99
11. Jackson C.H., MacDonald N.C., and Cornett J.W. Acetaminophen: a practical pharmacologic overview. Can. Med. Assoc. J. 131 (1984) 25-32 37
12. Kodama M., Hanasawa K., and Tani T. Blood purification for critical care medicine: endotoxin adsorption. Ther. Apher. 1 (1997) 224-227
13. Levy G., and Gwilt P.R. Effect of activated charcoal on acetaminophen absorption in man. Pharmacologist 16 (1974) 208
14. Michael M., Brittain M., Nagai J., Feld R., Hedley D., Oza A., Siu L., and Moore M.J. Phase II study of activated charcoal to prevent irinotecan-induced diarrhea. J. Clin. Oncol. 22 (2004) 4410-4417
15. Modi N.B., Veng-Pedersen P., Wurster D.E., Berg M.J., and Schottelius D.D. Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach. Pharm. Res. 11 (1994) 318-323
16. Nakamura T., and Ogawa S. Q&A: the reason for much attention clinically paid to acetaminophen and its good use. Pain Clinic 26 (2005) 1558-1559
17. Picchioni A.L. Activated charcoal. A neglected antidote. Pediatr. Clin. North Am. 17 (1970) 535-543
18. Swartz C.M., and Sherman A. The treatment of tricyclic antidepressant overdose with repeated charcoal. J. Clin. Psychopharmacol. 4 (1984) 336-340
19. Tsitoura A., Atta-Politou J., and Koupparis M.A. In vitro adsorption study of fluoxetine onto activated charcoal at gastric and intestinal pH using high performance liquid chromatography with fluorescence detector. J. Toxicol. Clin. Toxicol. 35 (1997) 269-276
20. Tsujikawa T., Araki Y., Makino J., Uda K., Ihara T., Sasaki M., Fujiyama Y., and Bamba T. Efficacy of oral adsorbent for treatment of peristomal fistula associated with Crohn's disease. J. Gastroenterol. 35 (2000) 296-298
21. Tye C.K., Sun C.C., and Amidon G.E. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J. Pharm. Sci. 94 (2005) 465-472
22. Van Wagenen R.A., Steggall M., Lentz D.J., and Andrade J.D. Activated carbons for medical applications. In vitro microparticle characterization and solute adsorption. Biomater. Med. Devices Artif. Organs 3 (1975) 319-364
23. Vertzoni M.V., Archontaki H.A., and Galanopoulou P. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose. J. Pharm. Biomed. Anal. 32 (2003) 487-493
24. Yamamoto K., Onishi H., Ito A., and Machida Y. Medicinal carbon tablets for treatment of acetaminophen intoxication: adsorption characteristics of medicinal carbon powder and its tablets. Chem. Pharm. Bull. 54 (2006) 359-362
25. Yamaoka K., Tanigawara Y., Nakagawa T., and Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4 (1981) 879-885